Investing Ideas
/
Indonesian Pharmaceuticals & Biotech High Insider Buying

Indonesian Pharmaceuticals & Biotech High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

1 companies

Kalbe Farma

Market Cap: Rp34.4t

Engages in the development, manufacture, and trading of pharmaceutical products in Indonesia.

KLBF

Rp760.00

4.8%

-49.7%